BIG
VNDA icon

Brooklyn Investment Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Brooklyn Investment Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-437
Closed -$2.09K – 2894
2024
Q4 		$2.09K Buy
+437
New +$2.1K ﹤0.01% 1445

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Brooklyn Investment Group's VNDA Position: Q1 2025 in Review

Brooklyn Investment Group sold out of Vanda Pharmaceuticals (VNDA) in Q1 2025, closing a stake of 437 shares — an estimated $2.09K sold.

Brooklyn Investment Group first reported a position in VNDA in Q4 2024 and held it in 1 quarter. The position peaked at $2.09K in Q4 2024. 146 funds tracked by Wall St. Rank hold VNDA as of Q1 2025.

  • Brooklyn Investment Group reported no remaining Vanda Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 437 Vanda Pharmaceuticals shares in Q1 2025, an estimated $2.09K.
  • Brooklyn Investment Group first reported a position in Vanda Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Brooklyn Investment Group's Vanda Pharmaceuticals position peaked at $2.09K in Q4 2024.
  • 146 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2025.

Based on Brooklyn Investment Group's 13F filing for Q1 2025, filed 13 May 2025.